Showing results (21-30 of 196) with videos related to
Sort By:
Pageof 20
International Journal of Molecular Medicine|October 13, 2000
Recombinant immunotoxins for the treatment of Hodgkin's disease (Review)B Matthey, A Engert, S BarthSeminars in Hematology|August 26, 1999
Treatment of advanced Hodgkin's lymphoma: standard and experimental approachesA Engert, J Wolf, V DiehlEuropean Journal of Haematology. Supplementum|July 13, 2005
Immunotherapy of Hodgkin's lymphomaP Borchmann, R Schnell, A EngertBehring Institute Mitteilungen|May 1, 1984
Experimental chemotherapy of heterotransplanted Hodgkin- and non-Hodgkin-lymphoma cell lines in nude miceH H Kirchner, A Engert, V DiehlCurrent Topics in Microbiology and Immunology|July 22, 1998
The emerging role of ricin A-chain immunotoxins in leukemia and lymphomaA Engert, E A Sausville, E VitettaKlinische Padiatrie|October 29, 1997
A staged protocol for the treatment of persistent pulmonary hypertension of the newbornS Sasse, A Kribs, A Vierzig, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphomaS Sasse, B Klimm, H Görgen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trialsP J Bröckelmann, H Müller, M Fuchs, et al.Annals of Hematology|July 12, 2001
Primary lymphoma of the conjunctiva--a rare manifestation of indolent non-Hodgkin's lymphomaM Reiser, A Josting, V Diehl, et al.Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Anti-angiogenesis: a new approach to tumor therapy?]D Schiefer, C Gottstein, V Diehl, et al.Pageof 20